[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
KEGG   DRUG: Istradefylline
Entry
D04641                      Drug                                   
Name
Istradefylline (JAN/USAN/INN);
Nourianz (TN);
Nouriast (TN)
Product
NOURIANZ (Kyowa Kirin)
Formula
C20H24N4O4
Exact mass
384.1798
Mol weight
384.43
Structure
Class
Neuropsychiatric agent
 DG01967  Antiparkinson agent
  DG01613  Xantine-type antiparkinsonian agent
Metabolizing enzyme substrate
 DG01891  CYP1A1 substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
 DG02925  CYP3A5 substrate
Metabolizing enzyme inhibitor
 DG02852  CYP3A/CYP3A4 inhibitor
  DG01522  CYP3A4 inhibitor
 DG01915  CYP3A5 inhibitor
Transporter inhibitor
 DG01622  ABCB1 inhibitor
Remark
Therapeutic category: 1169
ATC code: N04CX01
Product: D04641<JP/US>
Efficacy
Antiparkinsonian, Adenosine A2A receptor antagonist
  Disease
Parkinson's disease [DS:H00057]
Comment
Treatment of the symptoms of Parkinson's disease
Target
ADORA2A [HSA:135] [KO:K04266]
  Pathway
hsa04080  Neuroactive ligand-receptor interaction
hsa05012  Parkinson disease
Metabolism
Enzyme: CYP1A1 [HSA:1543], CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
Interaction
CYP inhibition: CYP3A4 [HSA:1576], CYP3A5 [HSA:1577]
Transporter inhibition: ABCB1 [HSA:5243]
Structure map
map07057  Antiparkinsonian agents
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N04 ANTI-PARKINSON DRUGS
   N04C OTHER ANTIPARKINSON DRUGS
    N04CX Other antiparkinson drugs
     N04CX01 Istradefylline
      D04641  Istradefylline (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
 Antiparkinson Agents
  Antiparkinson Agents, Other
   Istradefylline
    D04641  Istradefylline (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   116  Antiparkinsonian agents
    1169  Others
     D04641  Istradefylline (JAN/USAN/INN)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG01967  Antiparkinson agent
   DG01613  Xantine-type antiparkinsonian agent
    D04641  Istradefylline
 Metabolizing enzyme substrate
  DG01891  CYP1A1 substrate
   D04641  Istradefylline
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D04641  Istradefylline
  DG02925  CYP3A5 substrate
   D04641  Istradefylline
 Metabolizing enzyme inhibitor
  DG02852  CYP3A/CYP3A4 inhibitor
   DG01522  CYP3A4 inhibitor
    D04641  Istradefylline
  DG01915  CYP3A5 inhibitor
   D04641  Istradefylline
 Transporter inhibitor
  DG01622  ABCB1 inhibitor
   D04641  Istradefylline
Drug classes [BR:br08332]
 Neuropsychiatric agent
  DG01967  Antiparkinson agent
   D04641  Istradefylline
Target-based classification of drugs [BR:br08310]
 G Protein-coupled receptors
  Rhodopsin family
   Adenosine
    ADORA2A
     D04641  Istradefylline (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D04641
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D04641
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D04641
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D04641
 Drug transporters
  D04641
Other DBs
CAS: 155270-99-8
PubChem: 47206484
PDB-CCD: JQ9[PDBj]
LigandBox: D04641
KCF data

ATOM        28
            1   N4y N    14.8400  -16.6600
            2   C8y C    14.8400  -18.0600
            3   N4y N    13.6500  -18.7600
            4   C8y C    12.3900  -18.0600
            5   C8y C    12.3900  -16.6600
            6   C8y C    13.6500  -15.9600
            7   O5x O    13.6500  -14.5600
            8   N4y N    11.0585  -16.2274
            9   C8y C    10.2356  -17.3600
            10  N5x N    11.0585  -18.4926
            11  C1a C    10.6297  -14.9078
            12  O5x O    16.0553  -18.7551
            13  C1b C    13.6672  -20.1599
            14  C1a C    14.8751  -20.8376
            15  C1b C    16.0553  -15.9649
            16  C1a C    17.2437  -16.6577
            17  C2b C     8.8200  -17.3600
            18  C2b C     8.1200  -16.1476
            19  C8y C     6.7202  -16.1476
            20  C8x C     6.0297  -14.9520
            21  C8x C     4.6297  -14.9522
            22  C8y C     3.9299  -16.1647
            23  C8y C     4.6203  -17.3602
            24  C8x C     6.0203  -17.3601
            25  O2a O     2.5200  -16.1648
            26  O2a O     3.9205  -18.5727
            27  C1a C     2.5202  -18.5729
            28  C1a C     1.8179  -17.3812
BOND        30
            1     1   2 1
            2     2   3 1
            3     3   4 1
            4     4   5 2
            5     5   6 1
            6     1   6 1
            7     6   7 2
            8     5   8 1
            9     8   9 1
            10    9  10 2
            11    4  10 1
            12    8  11 1
            13    2  12 2
            14    3  13 1
            15   13  14 1
            16    1  15 1
            17   15  16 1
            18    9  17 1
            19   17  18 2
            20   18  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   22  23 1
            25   23  24 2
            26   19  24 1
            27   22  25 1
            28   23  26 1
            29   26  27 1
            30   25  28 1

» Japanese version   » Back

  All links  
Ontology (10)   
   KEGG BRITE (10)   
Pathway (1)   
   KEGG PATHWAY (1)   
Disease (1)   
   KEGG DISEASE (1)   
Drug (8)   
   KEGG DGROUP (7)   
   LigandBox (1)   
Chemical substance (2)   
   PubChem (1)   
   PDB-CCD (1)   
Gene (2)   
   KEGG ORTHOLOGY (1)   
   KEGG GENES (1)   
All databases (24)   

Download RDF
DBGET integrated database retrieval system